CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs AD with Concomitant NPH

V2, Crosslink

🧫

CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs AD with Concomitant NPH

active

experiment Created: 2026-04-02T10:01:41 By: crosslink-v2 Quality: 67% ✓ SciDEX ID: experiment-exp-wiki-experiments-nph-csf-

🧫 Experiment Protocol Clinicalproposed

SUMMARY

# CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs AD with Concomitant NPH ## Background and Rationale This innovative clinical study addresses a major diagnostic challenge in neurology by developing dynamic CSF biomarkers to differentiate normal pressure hydrocephalus (NPH) from Alzheimer's disease with concomitant NPH features. The clinical presentation of these conditions often overlaps significantly, leading to diagnostic uncertainty and suboptimal treatment decisions. Current sta

METHODOLOGY NOTES

**Phase 1: Patient Recruitment and Clinical Assessment (Months 1-8)** Recruit 200 participants across three groups: 75 patients with idiopathic normal pressure hydrocephalus (iNPH), 75 patients with Alzheimer's disease and concomitant NPH features (AD+NPH), and 50 age-matched controls. Inclusion criteria include age >60 years, clinical symptoms of gait disturbance and cognitive impairment, and ventricular enlargement (Evans index >0.3). Exclude patients with secondary causes of hydrocephalus, severe medical comorbidities, or contraindications to lumbar puncture. Perform comprehensive neuropsychological testing using Montreal Cognitive Assessment (MoCA), Timed Up and Go test, and NPH grading scale. Obtain amyloid PET imaging using [18F]florbetapir to confirm amyloid status in suspected AD+NPH cases. **Phase 2: CSF Dynamic Studies and Biomarker Analysis (Months 3-15)** Conduct CSF tap tests with pre- and post-drainage clinical assessments at 1, 6, 24, and 72 hours. Remove 30-50 mL CSF

▸Metadatasource: {'type': 'manual', 'source_name': 'wiki'

source	{'type': 'manual', 'source_name': 'wiki', 'extracted_by': 'backfill_v1', 'extraction_date': '2026-04-16T01:00:16.897543Z'}
summary	# CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs AD with Concomitant NPH ## Background and Rationale This innovative clinical study addresses a major diagnostic challenge in neurology by
entities	{'genes': ['AQP1/AQP4/KCNK2'], 'diseases': ["Alzheimer's Disease"]}
model_system	human
_schema_version	1
experiment_type	clinical
primary_outcome	Validate CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs AD with Concomitant NPH
methodology_notes	Phase 1: Patient Recruitment and Clinical Assessment (Months 1-8) Recruit 200 participants across three groups: 75 patients with idiopathic normal pressure hydrocephalus (iNPH), 75 patients with
replication_status	single_study
extraction_metadata	{'backfill_at': '2026-04-16T01:00:16.897548', 'needs_review': True, 'extraction_notes': 'Backfilled from wiki source (no PMID available)', 'extraction_confidence': 0.4}

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

100%

Debates

0

Incoming

662

Outgoing

477

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs AD with Concomitant NPH

derives from (16)

supports (76)

💬 Discussion